Stockholders’ Equity (Tables)
|
6 Months Ended |
Jun. 30, 2022 |
|---|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Schedule of Share Based Payments Award Stock Options Valuation Assumptions |
Schedule of Share Based Payments Award Stock Options Valuation Assumptions
Assumptions:
| |
|
2022 |
|
|
2021 |
|
| Dividend yield |
|
|
0.00 |
% |
|
|
0.00 |
% |
| Risk-free interest rate |
|
|
0.95-1.65 |
% |
|
|
0.19-0.32 |
% |
| Expected volatility |
|
|
106.4-110.0 |
% |
|
|
116.8-123.8 |
% |
| Expected life (in years) |
|
|
5 |
|
|
|
5 |
|
|
| Schedule of Stock Option Activity |
Option
activity for the six months ended June 30, 2022 and the year ended December 31, 2021 was as follows:
Schedule of Stock Option Activity
| |
|
Options |
|
|
Weighted Average Exercise Price ($) |
|
|
Weighted Average Remaining Contractual Life (Yrs.) |
|
|
Aggregate Intrinsic Value ($) |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Options outstanding at December 31, 2020 |
|
|
713,010 |
|
|
|
5.15 |
|
|
|
4.40 |
|
|
|
477,802 |
|
| Granted |
|
|
698,831 |
|
|
|
3.29 |
|
|
|
4.39 |
|
|
|
46,800 |
|
| Exercised |
|
|
(5,204 |
) |
|
|
2.50 |
|
|
|
- |
|
|
|
- |
|
| Forfeited or cancelled |
|
|
(10,755 |
) |
|
|
3.49 |
|
|
|
- |
|
|
|
- |
|
| Options outstanding at December 31, 2021 |
|
|
1,395,882 |
|
|
|
4.24 |
|
|
|
3.89 |
|
|
|
- |
|
| Granted |
|
|
162,000 |
|
|
|
2.50 |
|
|
|
4.69 |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Forfeited or cancelled |
|
|
(29,245 |
) |
|
|
4.54 |
|
|
|
- |
|
|
|
- |
|
| Options outstanding June 30, 2022 |
|
|
1,528,637 |
|
|
|
4.05 |
|
|
|
3.53 |
|
|
|
- |
|
| Options expected to vest in the future as of June 30, 2022 |
|
|
436,963 |
|
|
|
3.26 |
|
|
|
3.88 |
|
|
|
- |
|
| Options exercisable at June 30, 2022 |
|
|
1,091,674 |
|
|
|
4.37 |
|
|
|
3.39 |
|
|
|
- |
|
| Options vested, exercisable, and options expected to vest at June 30, 2022 |
|
|
1,528,637 |
|
|
|
4.05 |
|
|
|
3.53 |
|
|
|
- |
|
|
| Schedule of Warranty Activity |
Warrant
activity for the six months ended June 30, 2022 and the year ended December 31, 2021 was as follows:
Schedule
of Warranty Activity
| |
|
Warrants |
|
|
Weighted Average Exercise Price ($) |
|
|
Weighted Average Remaining Contractual Life (Yrs.) |
|
| Warrants outstanding at December 31, 2020 |
|
|
1,881,429 |
|
|
|
7.57 |
|
|
|
4.16 |
|
| Granted |
|
|
2,602,143 |
|
|
|
4.36 |
|
|
|
1.63 |
|
| Exercised |
|
|
(495,641 |
) |
|
|
2.59 |
|
|
|
4.13 |
|
| Forfeited or cancelled |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Warrants outstanding at December 31, 2021 |
|
|
3,987,931 |
|
|
|
6.10 |
|
|
|
2.10 |
|
| Granted |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Forfeited or cancelled |
|
|
(162,150 |
) |
|
|
40.00 |
|
|
|
- |
|
| Warrants outstanding at June 30, 2022 |
|
|
3,825,781 |
|
|
|
4.66 |
|
|
|
1.69 |
|
|
| Stock Appreciation Rights [Member] |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Schedule of Share Based Payments Award Stock Options Valuation Assumptions |
The
fair value of SAR awards was estimated using the Black-Scholes model with the following weighted-average assumptions for the six months
ended June 30, 2022 and the year ended December 31, 2021:
Schedule of Share Based Payments Award Stock Options Valuation Assumptions
Assumptions:
| |
|
2022 |
|
|
2021 |
|
| Dividend yield |
|
|
0.00 |
% |
|
|
0.00 |
% |
| Risk-free interest rate |
|
|
0.82-1.65 |
% |
|
|
0.39-0.40 |
% |
| Expected volatility |
|
|
108.4-119.0 |
% |
|
|
123.0 |
% |
| Expected life (in years) |
|
|
5 |
|
|
|
5 |
|
|
| Schedule of Stock Option Activity |
SARs
activity for the six months ended June 30, 2022 and the year ended December 31, 2021 was as follows:
Schedule of Stock Option Activity
| |
|
Options |
|
|
Weighted Average Exercise Price ($) |
|
|
Weighted Average Remaining Contractual Life (Yrs.) |
|
|
Aggregate Intrinsic Value ($) |
|
| |
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
|
|
| SARs outstanding at December 31, 2020 |
|
|
127,679 |
|
|
|
2.61 |
|
|
|
4.52 |
|
|
|
97,919 |
|
| Granted |
|
|
242,945 |
|
|
|
3.43 |
|
|
|
4.61 |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Forfeited or cancelled |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| SARs outstanding at December 31, 2021 |
|
|
370,624 |
|
|
|
3.15 |
|
|
|
4.24 |
|
|
|
- |
|
| Granted |
|
|
45,033 |
|
|
|
2.33 |
|
|
|
4.61 |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Forfeited or cancelled |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| SARs outstanding June 30, 2022 |
|
|
415,657 |
|
|
|
3.06 |
|
|
|
3.83 |
|
|
|
- |
|
| SARs expected to vest in the future as of June 30, 2022 |
|
|
297,674 |
|
|
|
3.24 |
|
|
|
4.02 |
|
|
|
- |
|
| SARs exercisable at June 30, 2022 |
|
|
117,983 |
|
|
|
2.62 |
|
|
|
3.37 |
|
|
|
- |
|
| SARs vested, exercisable, and SARs expected to vest at June 30, 2022 |
|
|
415,657 |
|
|
|
3.06 |
|
|
|
3.83 |
|
|
|
- |
|
|